Johnson & Johnson Requests Emergency Use Authorization From FDA

Credit: KDKA CBS 2 Pittsburgh

Duration: 02:29s 05 Feb 2021 0 shares 1 views

Johnson & Johnson Requests Emergency Use Authorization From FDA

In studies, the vaccine is 66 percent effective at preventing moderate or severe disease.

KDKA's Dr. Maria Simbra has more.

You might like

Related news coverage

Fauci urges Americans to get any of 3 vaccines

Fauci urges Americans to get any of 3 vaccines

Reuters - Politics 28 Feb 2021

[NFA] Dr. Anthony Fauci, the top U.S. infectious disease official, on Sunday urged Americans to take any of the three approved..

Johnson & Johnson's 1-Dose COVID Vaccine Given Full Emergency Authorization By FDA

Johnson & Johnson's 1-Dose COVID Vaccine Given Full Emergency Authorization By FDA

CBS4 Miami

28 Feb 2021

FDA Approves J&J's COVID-19 Vaccine For Emergency Use

FDA Approves J&J's COVID-19 Vaccine For Emergency Use

KDKA CBS 2 Pittsburgh

28 Feb 2021

FDA Approves Johnson & Johnson COVID Vaccine For Emergency Use

FDA Approves Johnson & Johnson COVID Vaccine For Emergency Use

CBS 2 New York

28 Feb 2021

Local Health Officials Optimistic Over Johnson & Johnson Vaccine

Local Health Officials Optimistic Over Johnson & Johnson Vaccine

KDKA CBS 2 Pittsburgh

28 Feb 2021

Advertisement

More coverage

FDA Grants Emergency Use Authorization For Johnson & Johnson's COVID-19 Vaccine

FDA Grants Emergency Use Authorization For Johnson & Johnson's COVID-19 Vaccine

WJZ Baltimore 28 Feb 2021

FDA Grants Emergency Use Authorization For Johnson & Johnson's COVID-19 Vaccine

FDA Authorizes Emergency Use Of Johnson & Johnson Vaccine, House Passes Relief Bill

FDA Authorizes Emergency Use Of Johnson & Johnson Vaccine, House Passes Relief Bill

CBS 2 New York

28 Feb 2021

Reporter Update: FDA Approves Johnson & Johnson Vaccine

Reporter Update: FDA Approves Johnson & Johnson Vaccine

KDKA CBS 2 Pittsburgh

28 Feb 2021

Friday 10 p.m. COVID-19 update

Friday 10 p.m. COVID-19 update

KMBC

27 Feb 2021

FDA Advisory Panel Gives Emergency Authorization To Johnson & Johnson's COVID Caccine

FDA Advisory Panel Gives Emergency Authorization To Johnson & Johnson's COVID Caccine

WBZ CBS Boston

27 Feb 2021